Literature DB >> 6201589

Delineation of a cross-reactive idiotype on human autoantibodies with antibody against a synthetic peptide.

P P Chen, S Fong, D Normansell, R A Houghten, J G Karras, J H Vaughan, D A Carson.   

Abstract

Antibody against a cross-reactive idiotype (CRI) on human IgM-rheumatoid factor (RF) antibodies was induced by immunization of rabbits with a synthetic peptide ( PSL2 ) corresponding to the second complementarity-determining region (CDR), and adjacent amino acid residues of the kappa light chain of the IgM-RF Sie . The anti-peptide antibody bound efficiently to IgM-RF proteins known to share a cross-reactive idiotype, and to their isolated kappa chains. The anti-CRI was absorbed by, and eluted from, a peptide-Sepharose affinity column. The antibody activity was inhibited by the free peptide in solution. The anti-peptide antibody thus identifies a public idiotype on human IgM-RF, that is largely dependent on the primary sequence of the second CDR of the light chain. Such peptide-induced antiidiotypes of predefined specificity may facilitate studies of the molecular basis of idiotypic cross-reactions, the inheritance and somatic diversification of antibody molecules, and the regulation of the idiotype network.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201589      PMCID: PMC2187296          DOI: 10.1084/jem.159.5.1502

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Individual Antigenic Specificity of Isolated Antibodies.

Authors:  H G Kunkel; M Mannik; R C Williams
Journal:  Science       Date:  1963-06-14       Impact factor: 47.728

2.  Antibodies with specificities to preselected protein regions evoked by free synthetic peptides representing protein antigenic sites or other surface locations: demonstration with myoglobin.

Authors:  D R Young; H E Schmitz; M Z Atassi
Journal:  Mol Immunol       Date:  1983-05       Impact factor: 4.407

3.  Antibodies that react with predetermined sites on proteins.

Authors:  J G Sutcliffe; T M Shinnick; N Green; R A Lerner
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

4.  Evolution of immunoglobulin V genes: evidence indicating that recently duplicated human V kappa sequences have diverged by gene conversion.

Authors:  D L Bentley; T H Rabbitts
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

Review 5.  Gene conversion: some implications for immunoglobulin genes.

Authors:  D Baltimore
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

6.  Suppression of in vitro monoclonal human rheumatoid factor synthesis by antiidiotypic antibody. Target cells and molecular requirements.

Authors:  W J Koopman; R E Schrohenloher; J C Barton; E C Greenleaf
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

7.  Human beta-endorphin: synthesis and characterization of analogs iodinated and tritiated at tyrosine residues 1 and 27.

Authors:  R A Houghten; W C Chang; C H Li
Journal:  Int J Pept Protein Res       Date:  1980-10

8.  Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity.

Authors:  H G Kunkel; V Agnello; F G Joslin; R J Winchester; J D Capra
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

9.  Similarities in the light chains of anti-gamma-globulins showing cross-idiotypic specificities.

Authors:  H G Kunkel; R J Winchester; F G Joslin; J D Capra
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

10.  Immunochemical analysis of the idiotypes of mouse myeloma proteins with specificity for levan or dextran.

Authors:  M Weigert; W C Raschke; D Carson; M Cohn
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

View more
  22 in total

1.  How well can an idiotope peptide mimic replace its parent idiotype in a synthetic peptide vaccine?

Authors:  James S Cavenaugh; Hsu-kun Wang; Jiang Sha; Corey Hansen; Kongnara Papangkorn; Richard S Smith; James N Herron
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

2.  Genetic basis for the cross-reactive idiotypes on the light chains of human IgM anti-IgG autoantibodies.

Authors:  P P Chen; K Albrandt; N K Orida; V Radoux; E Y Chen; R Schrantz; F T Liu; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Evolutionary origin of autoreactive determinants (autogens).

Authors:  T Kieber-Emmons; H Kohler
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Fine specificity, idiotypy, and nature of cloned heavy-chain variable region genes of murine monoclonal rheumatoid factor antibodies.

Authors:  A J Manheimer-Lory; M Monestier; B Bellon; F W Alt; C A Bona
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 5.  The idiotype-antiidiotype network in human autoimmunity.

Authors:  N I Abdou
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

6.  Monoclonal antibodies defining a minor and a private idiotope on human rheumatoid factors.

Authors:  J L Pasquali; D Storck
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

7.  Shared idiotypes and restricted immunoglobulin variable region heavy chain genes characterize murine autoantibodies of various specificities.

Authors:  M Monestier; A Manheimer-Lory; B Bellon; C Painter; H Dang; N Talal; M Zanetti; R Schwartz; D Pisetsky; R Kuppers
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

8.  Cloning and sequence determination of a human rheumatoid factor light-chain gene.

Authors:  F R Jirik; J Sorge; S Fong; J G Heitzmann; J G Curd; P P Chen; R Goldfien; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

Review 9.  Genes regulating rheumatoid factors.

Authors:  C A Bona
Journal:  Springer Semin Immunopathol       Date:  1988

10.  Variable region diversity in human circulating antibodies specific for the capsular polysaccharide of Haemophilus influenzae type b. Preferential usage of two types of VH3 heavy chains.

Authors:  G J Silverman; A H Lucas
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.